SEC Form 3 · accession 0002074701-26-000003
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Michael Lundquist
Officer — Chief Financial Officer
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649989
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.